â??Treating COVID-19 infection with inhaled corticosteroids - STOIC 2

YOU BREATHE WE CARE0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年7月25日

试验速览

暂无简介。

•1.Participant is willing and able to give informed consent
•2.Male or Female aged 18 years or above
•3.New onset of symptoms suggestive of COVID19 like new onset cough fever, loss of smell or taste within 7 or fewer days of participant being seen at visit 1
•4.Able and willing to comply with all trial requirements as per Investigator

•1.A known allergy to IMP
•2. Any known contraindication to IMP
•3. Patient currently prescribed inhaled or systemic corticosteroids
•4.Recent use, within the previous 7 days of inhaled or systemic corticosteroids
•5. Patient needs hospitalisation at time of study consent
•6. Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participantâ??s ability to participate in the trial.
•7. Participants who have participated in another research trial involving an investigational product in the past 12 weeks

发起方

YOU BREATHE WE CARE